Job Description

Bei Roche kannst du ganz du selbst sein und wirst fur deine einzigartigen Qualitaten geschatzt. Unsere Kultur fordert personlichen Ausdruck, offenen Dialog und echte Verbindungen. Hier wirst du fur das, was du bist, wertgeschatzt, akzeptiert und respektiert. Dies schafft ein Umfeld, in dem du sowohl personlich als auch beruflich wachsen kannst. Gemeinsam wollen wir Krankheiten vorbeugen, stoppen und heilen und sicherstellen, dass jeder Zugang zur Gesundheitsversorgung hat - heute und in Zukunft. Werde Teil von Roche, wo jede Stimme zahlt.


Die Position
Our Global Pharma Strategy (GPS) team plays a pivotal role in shaping the future of healthcare by driving the strategic direction of our innovative product portfolio. As a member of the GPS team, you will be at the forefront of transforming groundbreaking scientific discoveries into accessible and impactful healthcare solutions for patients worldwide. We are seeking a dynamic and visionary professional who thrives in a collaborative environment and is passionate about making a difference.


Cardiovascular, Renal, and Metabolism (CVRM) is a new and important therapy area at Roche. We are building a broad and deep pipeline of assets with the potential to significantly impact people living with chronic diseases across obesity, diabetes (Type 1 and Type 2), MASH, and cardiovascular diseases (HTN, ASCVD, etc.). As a team, we hold overall accountability for late-stage assets by leading and connecting the organization via asset-specific life cycle teams. We also provide strategic insights and guidance to research and early development for internal and external innovation in the CVRM space. We pride ourselves on understanding the external ecosystem and competitive environment to develop impactful strategies that will advance standards of care and become best-in-disease/class medicines upon launch. We aim to challenge the status quo, empower patients to achieve their full potential in life, and know that every step counts.


You will be responsible for our CT-868 asset, which is entering Phase 3 for the treatment of Type 1 Diabetes in early 2026. CT-868 (GLP-1/GIP co-agonist) has the potential to be an important adjacent treatment to insulin management in a population with significant unmet needs. Type 1 Diabetes is also an area with strong synergies with our colleagues in Roche Diagnostics and innovative solutions, creating additional value for patients and providers, which will be explored.


The Opportunity

Lifecycle excellence:

ability to extend the assets potential by evaluating and triggering different value levers.

Value earlier:

Flex earlier in the lifecycle to create seamless transition from early to late stage (e.g. provide relevant input into the one asset team at critical time points such as piv enabling CDP). Lead molecule optimization within and across relevant therapeutic areas to ensure critical decisions are made which could impact value capture, including but not limited to device, diagnostics and digital ecosystem build. Shaping the long-term vision and strategy for one or several molecule programs - which can be large and/or complex in partnership with early development, Pharma Development, Global Pharma Strategy, Pharma Development Medical Affairs leads and respective external partners. Supporting relevant early development asset teams, licensing, and other business development activities. Strong collaboration with the Global Development Team and Commercial Leadership Team to realize the potential of the asset. Serving as a thought partner and sounding board for the GPS teams and relevant internal and external stakeholders, ensuring that franchise and enterprise goals are met. Serving as an inspiring leader, aligning people towards a vision while building a culture of accountability, collaboration, inclusion, and trust.

Who You AreA Bachelor's Degree is required, preferably in a marketing, business management, or life sciences discipline. MD, PhD, or other relevant Graduate, Postgraduate Degree or MBA (depending on the Lifecycle of the product) and TA experience are preferred. Demonstrable previous accomplishments should include developing and overseeing the execution of breakthrough development and/or commercial strategies that led to considerable financial results. Extensive experience in launch planning and management, as well as an ability to quickly develop a deep understanding of global health systems, access and reimbursement challenges, and product life-cycle planning. Role requires outstanding leadership skills with a proven track record in building teams and the ability to influence in a cross-functional environment. You should have exceptional strategic orientation and agility, with an outstanding ability to develop a long-term vision and a deep understanding of the global pharmaceutical/biotechnology industry to create robust and innovative business strategies.

Preferred Candidate Profile:

The ideal candidate has relevant disease area experience and understands the unique opportunities and challenges in Type 1 Diabetes. You have demonstrated your ability to lead large teams across the full value chain in previous roles and effectively navigate large matrix organizations. You lead by example, inspire teams to challenge the status quo, and thrive in a dynamic, high-paced environment. You are a strategic thinker focused on strategy execution and take pride in defining clear priorities and formulating strategic choices that will give us an edge against the competition and ensure relevance for patients and health systems. You enjoy a good scientific discussion, understand value chain complexities, and have the drive and ambition to deliver outstanding commercial performance. Lastly, you are a team player who contributes to creating an inclusive and informal culture. You care for your colleagues, dare to speak up, and do not take yourself too seriously.

What success looks like in the role:

+

Maximizing Value:

Success is achieved by maximizing the product's lifecycle value to patients, society, and the company.
+

Execution and Financial Targets:

Ensuring the timely, on-target, and within-budget delivery of the product strategy, including meeting key milestones and financial targets for the product.
+

Leadership and Accountability:

A key measure of success is the ability to effectively develop a high performing team by influencing internal and external stakeholders.


Ready for the next step? We look forward to hearing from you. Apply now to discover this exciting opportunity!


Wer wir sind
Eine gesundere Zukunft treibt uns zur Innovation an. Mehr als 100.000 Mitarbeiter weltweit arbeiten gemeinsam daran, wissenschaftliche Fortschritte zu erzielen und sicherzustellen, dass jeder Zugang zur Gesundheitsversorgung hat - heute und fur zukunftige Generationen. Durch unser Engagement werden uber 26 Millionen Menschen mit unseren Medikamenten behandelt und mehr als 30 Milliarden Tests mit unseren Diagnostik-Produkten durchgefuhrt. Wir ermutigen uns gegenseitig, neue Moglichkeiten zu erkunden, Kreativitat zu fordern und hohe Ziele zu setzen, um lebensverandernde Gesundheitslosungen zu liefern.


Gemeinsam konnen wir eine gesundere Zukunft gestalten.

Roche ist ein Arbeitgeber, der die Chancengleichheit fordert.